Is Axon Stock Increasing Your Market Risk?
π AXON shares demonstrated an annual volatility of 62.0% over the past year, significantly higher than the S&P 500's 12.7%, causing the stock to fall more than twice as far on average market down days.
π Sales for Axon grew 35% from a year earlier in fiscal Q2 2026, which ended June 30, 2026, indicating robust top-line expansion despite high market risk.
π° Operating margins improved to 5.2% in fiscal Q2 2026, up from a small loss a year prior, though management acknowledged margin pressure from scaling counter-drone systems.
π Over the five years to October 27, 2026, AXON returned 19.5% annually compared to 12.5% for the S&P 500, but generated only about 0.385 points of return per point of volatility versus 0.735 for the index.
π The stock's correlation with the broader market was loose at 0.32 over the past year, meaning Axon often moves independently of the S&P 500 direction.
π Investors are advised to watch fiscal Q3 2026 operating margins due in November 2026 as the critical indicator for whether fast sales growth will translate into wider profits.
- Axon reported a 35% year-over-year sales growth in fiscal Q2 2026, demonstrating strong demand for its TASER devices and body cameras.
- The company successfully turned around its profitability, achieving a 5.2% operating margin in fiscal Q2 2026 after posting a small loss the previous year.
- Over the five-year period ending October 27, 2026, AXON delivered an annualized return of 19.5%, outperforming the S&P 500's 12.5% return.
- The stock exhibited extreme volatility with a 62.0% annual reading over the past year, causing it to fall more than twice as far as the S&P 500 on average market down days.
- Management stated that scaling newer businesses, specifically counter-drone systems, is currently taking a hit to operating margins.
- Over the five-year period, AXON generated only about half the return per unit of risk taken compared to the S&P 500, indicating lower risk-adjusted performance.